Symbol="ETNB"
AssetType="Common Stock"
Name="89bio Inc"
Description="89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardiometabolic diseases. The company is headquartered in San Francisco, California."
CIK="1785173"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="535 MISSION STREET, 14TH FLOOR, SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1170997000"
EBITDA="-105604000"
PERatio="None"
PEGRatio="None"
BookValue="6.12"
DividendPerShare="0"
DividendYield="0"
EPS="-2.07"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.21"
ReturnOnEquityTTM="-0.384"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.07"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="37.44"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="3.111"
EVToRevenue="-"
EVToEBITDA="-2.924"
Beta="0.724"
num_52WeekHigh="22.93"
num_52WeekLow="3.6"
num_50DayMovingAverage="18.34"
num_200DayMovingAverage="13.94"
SharesOutstanding="72868000"
DividendDate="None"
ExDividendDate="None"
symbol="ETNB"
open="16.03"
high="16.34"
low="15.88"
price="16.25"
volume="832106.00"
latest_trading_day="2023-08-04"
previous_close="16.07"
change="0.18"
change_percent="1.1201%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="7"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="93"
Volume_recent_avg="1965766"
Change_recent_avg="-0.04"
Delta_recent_avg="1.07"
Variance_recent_avg="0.53"
Change_ratio_recent_avg="-0.32"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="93"
Aroon_momentum_negative="7"
image_negative_thumbnail_id_1="138"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0038.jpeg"
image_negative_thumbnail_id_2="1166"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_neutral_thumbnail_id_1="597"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="976"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_positive_thumbnail_id_2="650"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
